Literature DB >> 10364117

Risk factors for erysipelas of the leg (cellulitis): case-control study.

A Dupuy1, H Benchikhi, J C Roujeau, P Bernard, L Vaillant, O Chosidow, B Sassolas, J C Guillaume, J J Grob, S Bastuji-Garin.   

Abstract

OBJECTIVE: To assess risk factors for erysipelas of the leg (cellulitis).
DESIGN: Case-control study.
SETTING: 7 hospital centres in France.
SUBJECTS: 167 patients admitted to hospital for erysipelas of the leg and 294 controls.
RESULTS: In multivariate analysis, a disruption of the cutaneous barrier (leg ulcer, wound, fissurated toe-web intertrigo, pressure ulcer, or leg dermatosis) (odds ratio 23.8, 95% confidence interval 10.7 to 52.5), lymphoedema (71.2, 5.6 to 908), venous insufficiency (2.9, 1.0 to 8.7), leg oedema (2.5, 1.2 to 5.1) and being overweight (2.0, 1.1 to 3.7) were independently associated with erysipelas of the leg. No association was observed with diabetes, alcohol, or smoking. Population attributable risk for toe-web intertrigo was 61%.
CONCLUSION: This first case-control study highlights the major role of local risk factors (mainly lymphoedema and site of entry) in erysipelas of the leg. From a public health perspective, detecting and treating toe-web intertrigo should be evaluated in the secondary prevention of erysipelas of the leg.

Entities:  

Mesh:

Year:  1999        PMID: 10364117      PMCID: PMC28138          DOI: 10.1136/bmj.318.7198.1591

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

Review 1.  Dermo-hypodermal bacterial infections. Current concepts.

Authors:  P Bernard
Journal:  Eur J Med       Date:  1992-05

2.  [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].

Authors:  B Crickx; F Chevron; M Sigal-Nahum; S Bilet; F Faucher; C Picard; I Lazareth; S Belaich
Journal:  Ann Dermatol Venereol       Date:  1991       Impact factor: 0.777

3.  Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections.

Authors:  M Kremer; R Zuckerman; Z Avraham; R Raz
Journal:  J Infect       Date:  1991-01       Impact factor: 6.072

4.  Selection of controls in case-control studies. II. Types of controls.

Authors:  S Wacholder; D T Silverman; J K McLaughlin; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

Review 5.  Erysipelas: an update.

Authors:  C Chartier; E Grosshans
Journal:  Int J Dermatol       Date:  1996-11       Impact factor: 2.736

6.  Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples.

Authors:  J D Semel; H Goldin
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

7.  Erysipelas: clinical and bacteriologic spectrum and serological aspects.

Authors:  B Eriksson; C Jorup-Rönström; K Karkkonen; A C Sjöblom; S E Holm
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 8.  Streptococcal infections of skin and soft tissues.

Authors:  A L Bisno; D L Stevens
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Antibiotic prophylaxis in recurrent erysipelas.

Authors:  A C Sjöblom; B Eriksson; C Jorup-Rönström; K Karkkonen; M Lindqvist
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

10.  Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique.

Authors:  P Bernard; C Bedane; M Mounier; F Denis; G Catanzano; J M Bonnetblanc
Journal:  Arch Dermatol       Date:  1989-06
View more
  71 in total

1.  Diagnosis and management of cellulitis.

Authors:  Tadhg Sullivan; Eoghan de Barra
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

2.  Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.

Authors:  Kim Ekelund; Peter Skinhøj; Jesper Madsen; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

4.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

5.  Recurrent cellulitis with benzathine penicillin prophylaxis is associated with diabetes and psoriasis.

Authors:  M Karppelin; T Siljander; H Huhtala; A Aromaa; J Vuopio; K Hannula-Jouppi; J Kere; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-25       Impact factor: 3.267

6.  Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study.

Authors:  Elana Katz; Nicole L Dugan; Joy C Cohn; Christina Chu; Rebecca G Smith; Kathryn H Schmitz
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

Review 7.  New developments in clinical aspects of lymphatic disease.

Authors:  Peter S Mortimer; Stanley G Rockson
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

8.  Low-dose penicillin for recurrent cellulitis?

Authors:  Liz Nguyen; Kate Rowland
Journal:  J Fam Pract       Date:  2014-01       Impact factor: 0.493

9.  Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis.

Authors:  J Carratalà; B Rosón; N Fernández-Sabé; E Shaw; O del Rio; A Rivera; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

10.  Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Prevention of Breast Cancer-Related Lymphedema-a Preliminary Report.

Authors:  Juhi Agrawal; Sandeep Mehta; Ashish Goel; Pankaj Kumar Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2018-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.